We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$125B
AUM Growth
+$2.58B
Cap. Flow
-$3.77B
Cap. Flow %
-3.02%
Top 10 Hldgs %
25.94%
Holding
7,845
New
463
Increased
3,647
Reduced
2,883
Closed
246

Sector Composition

Rank Sector Weight
1 Financials 4.66%
2 Technology 4.22%
3 Healthcare 2.96%
4 Consumer Discretionary 2.91%
5 Industrials 2.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRLN
5226
DELISTED
Marlin Business Services Corp
MRLN
$149K ﹤0.01%
6,644
+537
+9% +$13.3K
GLOB icon
5227
Globant
GLOB
$1.58B
$148K ﹤0.01%
3,178
-6
-0.2% -$241
RELX icon
5228
RELX
RELX
$61.8B
$148K ﹤0.01%
6,255
+1,886
+43% +$43.8K
MLNT
5229
CALL
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$148K ﹤0.01%
+1,872
New +$139K
PSDO
5230
DELISTED
Presidio, Inc. Common Stock
PSDO
$148K ﹤0.01%
7,733
+2,623
+51% +$41.2K
PIV
5231
DELISTED
PWSHS S&P 500 HIGH QTY PORTF S&P HIGH QTY RKGS INDEX
PIV
$148K ﹤0.01%
4,850
-100
-2% -$3.05K
AVD icon
5232
American Vanguard Corp
AVD
$68.4M
$147K ﹤0.01%
7,507
-7,532
-50% -$156K
EVT icon
5233
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
$2.1B
$147K ﹤0.01%
6,335
+1,775
+39% +$40.1K
KURA icon
5234
Kura Oncology
KURA
$800M
$147K ﹤0.01%
9,585
+2,925
+44% +$43.1K
NBIX icon
5235
CALL
Neurocrine Biosciences
NBIX
$16.8B
$147K ﹤0.01%
1,900
-1,500
-44% -$102K
NRIM icon
5236
Northrim BanCorp
NRIM
$590M
$147K ﹤0.01%
17,352
-504
-3% -$4.41K
BPMP
5237
DELISTED
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
$147K ﹤0.01%
+7,153
New +$130K
LQDT icon
5238
Liquidity Services
LQDT
$1.22B
$146K ﹤0.01%
29,988
-16,182
-35% -$88.1K
PCRX icon
5239
CALL
Pacira BioSciences
PCRX
$1.04B
$146K ﹤0.01%
3,200
+2,600
+433% +$103K
VNOM icon
5240
Viper Energy
VNOM
$8.71B
$146K ﹤0.01%
6,274
+2,095
+50% +$42.5K
MDLY
5241
DELISTED
Medley Management Inc
MDLY
$146K ﹤0.01%
2,252
+66
+3% +$4.11K
RESI
5242
DELISTED
Front Yard Residential Corporation Common Stock
RESI
$146K ﹤0.01%
12,301
-8,854
-42% -$97.9K
JGH icon
5243
Nuveen Global High Income Fund
JGH
$352M
$145K ﹤0.01%
8,543
RQI icon
5244
Cohen & Steers Quality Income Realty Fund
RQI
$1.7B
$145K ﹤0.01%
11,425
+6
+0.1% +$75
TDW icon
5245
Tidewater
TDW
$3.73B
$145K ﹤0.01%
5,939
+265
+5% +$6.94K
UEIC icon
5246
Universal Electronics
UEIC
$57.8M
$145K ﹤0.01%
3,063
-1,035
-25% -$57.4K
CRTO icon
5247
Criteo S.A. Ordinary Shares
CRTO
$1.1B
$144K ﹤0.01%
5,531
+5,431
+5,431% +$194K
EFR
5248
Eaton Vance Senior Floating-Rate Fund
EFR
$312M
$144K ﹤0.01%
10,001
-755
-7% -$10.9K
IFLN
5249
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$308M
$144K ﹤0.01%
7,621
+1,795
+31% +$34.1K
TBBK icon
5250
The Bancorp
TBBK
$2.79B
$144K ﹤0.01%
14,566
+14,411
+9,297% +$132K

Similar funds

Citigroup's Q4 2017 Portfolio in Review

As of Q4 2017, Citigroup held 7,845 positions worth $125B, up 2.1% from $122B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Citigroup withdrew a net $3.77B in Q4 2017, closing 246 positions and reducing 2,883 holdings. Its most notable exit was CR Bard Inc., an estimated $210M position sold in full.

By sector, the portfolio is most concentrated in Financials at 4.7% of assets, up from 4.4% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Citigroup opened a new position in Global X US Preferred ETF worth $19.9M.

  • Citigroup's largest Q4 2017 buy was Global X US Preferred ETF: 800,000 shares worth $19.9M.
  • Citigroup added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2017, an estimated $341M increase.
  • Citigroup's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.83B.
  • Citigroup fully exited CR Bard Inc. in Q4 2017, selling an estimated $210M.
  • Citigroup's ten largest holdings make up 26% of its $125B portfolio in Q4 2017.
  • Citigroup opened 463 new positions and closed 246 in Q4 2017.
  • Citigroup's portfolio value rose 2.1% quarter-over-quarter to $125B.

Based on Citigroup's 13F filing for Q4 2017, filed 12 Feb 2018.